Shopping Cart
- Remove All
- Your shopping cart is currently empty
JNJ-63576253 is a Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $39 | In Stock | |
5 mg | $64 | In Stock | |
10 mg | $113 | In Stock | |
25 mg | $247 | In Stock | |
50 mg | $396 | In Stock | |
100 mg | $589 | In Stock | |
1 mL x 10 mM (in DMSO) | $76 | In Stock |
Description | JNJ-63576253 is a Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC). |
Targets&IC50 | Androgen receptor:37nM |
In vitro | JNJ-63576253 inhibits the growth of VCaP cells,with an IC50 of 265nM[1]. |
Molecular Weight | 538.97 |
Formula | C23H22ClF3N6O2S |
Cas No. | 2110428-64-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 200 mg/mL (371.08 mM) H2O: insoluble | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.